Elan is Focused on Serious Debilitating Diseases

As a neuroscience-based biotechnology company, Elan is focused on discovering, developing, manufacturing and marketing the most advanced therapies in neuroscience and autoimmune diseases. Our company offers the expertise of many of the world’s leading scientists and with more than two decades of scientific research experience, Elan is well positioned to provide new and innovative therapies to patients suffering from the most debilitating neurological disorders.

In neuroscience, Elan is building upon its breakthrough research and extensive experience in the area of neuropathology-related disorders, such as Alzheimer’s disease and Parkinson’s disease. In autoimmune diseases, Elan’s primary emphasis is studying cell trafficking to discover ways to provide disease-modifying therapies for multiple sclerosis and inflammatory bowel disease.

It is the patients and families impacted by these chronic and debilitating diseases that inspire our passion to find new and better treatments.